Compare EOG Resources Inc (EOG) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EOG Resources Inc vs TransMedics Group Inc — how do they compare? EOG Resources Inc trades at $142.47 (market cap $75.22B), while TransMedics Group Inc trades at $87.57 (market cap $3.10B). The key difference: EOG Resources Inc is far larger — about 24.3× TransMedics Group Inc's market cap, and EOG Resources Inc pays a 2.85% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| EOG | TMDX | |
|---|---|---|
Market Cap | $75.22B | $3.10B |
Sector | Energy | Technology |
52-Week High | $149.89 | $150.42 |
52-Week Low | $101.78 | $61.99 |
Enterprise Value | $78.56B | $3.49B |
Dividend Yield | 2.85% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $142.4, up 0.13% today, with a bullish technical signal and strong fundamentals. The stock shows robust profitability with a 25.81% net income margin and a low P/E of 11.16. Recent Q2 2026 earnings of $5.07 per share beat estimates, driven by higher oil prices and production. Analyst consensus is a Buy with a $157.88 price target, and institutional interest remains positive.
The outlook for EOG is favorable, supported by consistent earnings beats, shareholder returns via dividends, and a disciplined growth strategy. Key risks include oil price volatility and capital expenditure outflows. The stock presents a value opportunity with upside potential, but investors should monitor energy market trends and execution on international projects.
TransMedics Group (TMDX) trades at $86.43, down 2.24% amid recent earnings misses but maintains strong analyst support with a $99.57 consensus target. The stock shows bullish technical signals with support at $84-87, though RSI levels suggest overbought conditions. Fundamentally, the company demonstrates robust profitability with 58.69% gross margins and 22.69% net income margins, despite recent quarterly earnings falling short of expectations.
Investment outlook remains positive given strong institutional backing and growth potential in organ transplant technology, though risks include ongoing fiduciary investigations and margin pressure from increased operating costs. The stock offers 15% upside to consensus targets but requires monitoring of Q3 earnings performance and legal developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
